• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Copper Bis-3,5-diisopropylsalicylate

Copper Bis-3,5-diisopropylsalicylate

Product ID C5662
Cas No. 21246-18-4
Purity ≥97%
Product Unit SizeCostQuantityStock
1 g $108.50 In stock
5 g $325.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Copper bis-3,5-diisopropylsalicylate exhibits anti-diabetic, analgesic, antioxidative, immunomodulatory, anti-fibrotic, and anticancer chemotherapeutic activities. Copper bis-3,5-diisopropylsalicylate decreases hyperglycemia and DNA damage in diabetic rats and also exhibits radical scavenging and electron accepting abilities in other models. This compound increases levels of bronchoalveolar cells and neutrophils, decreases levels of macrophages and lymphocytes, and suppresses the development of lung fibrosis in animal models. Additionally, copper bis-3,5-diisopropylsalicylate decreases tumor growth and increases survival rates in animal models of mammary cancer.

Product Info

Cas No.

21246-18-4

Purity

≥97%

Formula

C26H34O6Cu

Formula Wt.

506.11

IUPAC Name

copper;2-carboxy-4,6-di(propan-2-yl)phenolate

Synonym

Cu(II) (3,5-diisopropylsalicylate)

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

C5662 MSDS PDF

Info Sheet

C5662 Info Sheet PDF

References

Qazzaz M, Abdul-Ghani R, Metani M, et al. The antioxidant activity of copper(II) (3,5-diisopropyl salicylate)4 and its protective effect against streptozotocin-induced diabetes mellitus in rats. Biol Trace Elem Res. 2013 Jul;154(1):88-96. PMID: 23677849.

Baquial JG, Sorenson JR. Down-regulation of NADPH-diaphorase (nitric oxide synthase) may account for the pharmacological activities of Cu(II)2 (3,5-diisopropylsalicylate)4. J Inorg Biochem. 1995 Nov 1;60(2):133-48. Erratum in: J Inorg Biochem. 1997 Nov 15;68(3):233. PMID: 8530918.

Denis M. Antioxidant therapy partially blocks immune-induced lung fibrosis. Inflammation. 1995 Apr;19(2):207-19. PMID: 7601506.

Crispens CG Jr, Sorenson JR. Activity of CuDIPS against mammary cancer in C3H HeNCR mice. Anticancer Res. 1992 Jul-Aug;12(4):1271-3. PMID: 1503420.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G8800

    GW-788388

    ALK5 (activin-like) antagonist.

    ≥97%
  • A3208

    AICAR

    AMPK activator.

    ≥98%
  • A5034

    4-Aminosalicylic Sodium Dihydrate

    Dihydrofolate reductase inhibitor.

    ≥98%
  • R8076

    Rutin Hydrate

    Flavonoid glycoside found in fruit, asparagus, ...

    ≥95%
  • P0397

    Pazopanib

    VEGFR, PDGFR, c-Kit inhibitor.

    ≥97%
  • C3479

    Citrinin

    Mycotoxin produced by Penicillum, Aspergillus, ...

    ≥98%
  • C8502

    CV-70

    1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...

    ≥70%
  • N1656

    D-(+)-Neopterin

    Endogenous pteridine metabolite of GTP.

    ≥98%
  • A5056

    Amorolfine Hydrochloride

    14α-demethylase inhibitor.

    ≥98.5%
  • M5793

    Moxifloxacin Free Base

    Fluoroquinolone; topoisomerase IV, topoisomeras...

    ≥98%
  • V1769

    Verapamil Hydrochloride

    L-type Ca2+ channel blocker.

    ≥98%
  • U6957

    Urotensin I

    Endogenous peptide, involved in stress signalin...

    ≥95%
  • B1973

    Besifloxacin Hydrochloride

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • J6400

    (+)-JQ-1

    Triazolothienodiazepine; BRD inhibitor.

    ≥99%
  • F4501

    Flavanone

    Variety of flavonoid found in various plant sou...

    ≥98%
  • M1777

    R-(−)-α-Methylbenzyl Isothiocyanate

    ITC, used as chiral agent.

    ≥98%
  • A5378

    Antimycin A

    Oxidative phosphorylation inhibitor.

  • E7377

    Estriol

    Endogenous steroid hormone, estradiol metabolit...

    ≥97%
  • C458567

    Clofazimine

    Antibacterial (Antimyobacterial) agent.

    ≥99%
  • N1979

    Neuromedin

    Endogenous proneurotensin peptide, involved in ...

    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only